Synthetic rescue

Synthetic rescue (or synthetic recovery or synthetic viability when a lethal phenotype is rescued [1][2]) refers to a genetic interaction in which a cell that is nonviable, sensitive to a specific drug, or otherwise impaired due to the presence of a genetic mutation becomes viable when the original mutation is combined with a second mutation in a different gene.[1] The second mutation can either be a loss-of-function mutation (equivalent to a knockout) or a gain-of-function mutation.[2]

Synthetic rescue could potentially be exploited for gene therapy, but it also provides information on the function of the genes involved in the interaction.

  1. ^ a b Motter, Adilson E; Gulbahce, Natali; Almaas, Eivind; Barabási, Albert-László (2008). "Predicting synthetic rescues in metabolic networks". Molecular Systems Biology. 4: 168. arXiv:0803.0962. doi:10.1038/msb.2008.1. ISSN 1744-4292. PMC 2267730. PMID 18277384.
  2. ^ a b Puddu, F.; Oelschlaegel, T; Guerini, I; Geisler, NJ; Niu, H; Herzog, M; Salguero, I; Ochoa-Montaño, B; Viré, E; Sung, P; Adams, DJ; Keane, TM; Jackson, SP (2015). "Synthetic viability genomic screening defines Sae2 function in DNA repair". EMBO Journal. 34 (11): 1509–1522. doi:10.15252/embj.201590973. PMC 4474527. PMID 25899817.